Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001171520-23-000104
Filing Date
2023-02-14
Accepted
2023-02-13 18:04:18
Documents
1
Group Members
HABIB KAIROUZJOSHUA RUCHKARIBA LLCMARK LESCHLYPINNACLE INVESTMENT PARTNERS Q-6, L.P.PINNACLE MANAGEMENT PARTNERS LLCRHO CAPITAL PARTNERS LLCRHO VENTURES V AFFILIATES, L.L.C.RHO VENTURES V, L.P.RMV V, L.L.C.RUGU3 LLC

Document Format Files

Seq Description Document Type Size
1 eps10650_mersana.htm SC 13G/A 198368
  Complete submission text file 0001171520-23-000104.txt   200411
Mailing Address C/O RHO CAPITAL PARTNERS, INC. 152 WEST 57TH STREET, 23RD FLOOR NEW YORK NY 10019
Business Address C/O RHO CAPITAL PARTNERS, INC. 152 WEST 57TH STREET, 23RD FLOOR NEW YORK NY 10019 212-751-6677
Rho Ventures V, L.P. (Filed by) CIK: 0001325383 (see all company filings)

EIN.: 201953730 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90033 | Film No.: 23620590
SIC: 2834 Pharmaceutical Preparations